Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma.
作者： Robert F. Cornell , Bonnie Ky , Brendan M. Weiss , Cherie N. Dahm , Deepak K. Gupta
DOI: 10.1200/JCO.19.00231
关键词:
摘要: PURPOSECardiovascular adverse events (CVAEs) can occur during proteasome inhibitor (PI) therapy. We conducted a prospective, observational, multi-institutional study to define risk factors and outc...
sci-hub.se 参考文章(5)
Carolyn S P Lam, Adriaan A Voors, Rudolf A de Boer, Scott D Solomon, Dirk J van Veldhuisen, Heart failure with preserved ejection fraction: from mechanisms to therapies European Heart Journal. ,vol. 39, pp. 2780- 2792 ,(2018) , 10.1093/EURHEARTJ/EHY301
Xinwei Yang, Xiyun Zhao, Xiaoxia Wang, Compound kushen injection for multiple myeloma: A protocol of systematic review and meta-analysis. Medicine. ,vol. 98, ,(2019) , 10.1097/MD.0000000000018257
John G F Cleland, Alexander R Lyon, Theresa McDonagh, John J V McMurray, The year in cardiology: heart failure European Heart Journal. ,vol. 41, pp. 1232- 1248 ,(2020) , 10.1093/EURHEARTJ/EHZ949
Michael A Biersmith, Matthew S Tong, Avirup Guha, Orlando P Simonetti, Daniel Addison, None, Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies. Journal of the American Heart Association. ,vol. 9, ,(2020) , 10.1161/JAHA.119.013755
Rajshekhar Chakraborty, Navneet S. Majhail, Treatment and disease-related complications in multiple myeloma: Implications for survivorship. American Journal of Hematology. ,vol. 95, pp. 672- 690 ,(2020) , 10.1002/AJH.25764